Financhill
Sell
15

ADTX Quote, Financials, Valuation and Earnings

Last price:
$0.78
Seasonality move :
-17.89%
Day range:
$0.76 - $0.87
52-week range:
$0.76 - $5,867.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
25.68x
P/B ratio:
0.16x
Volume:
298.3K
Avg. volume:
3M
1-year change:
-99.98%
Market cap:
$396.1K
Revenue:
$134K
EPS (TTM):
-$5,501.56

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ADTX
Aditxt, Inc.
-- -- -- -- --
CATX
Perspective Therapeutics, Inc.
$231.1K -$0.35 -9.65% -37.91% $12.3077
ELMD
Electromed, Inc.
$18M -- 11.04% -- $36.00
INFU
InfuSystem Holdings, Inc.
$36.7M $0.05 8.36% 39.86% $14.20
LUNG
Pulmonx Corp.
$21.7M -$0.39 -8.57% -15.65% $5.75
QSI
Quantum-Si, Inc.
$762K -$0.13 -36.07% -42.58% $2.68
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ADTX
Aditxt, Inc.
$0.79 -- $396.1K -- $0.00 0% 25.68x
CATX
Perspective Therapeutics, Inc.
$2.8400 $12.3077 $211.1M -- $0.00 0% 192.56x
ELMD
Electromed, Inc.
$28.80 $36.00 $240.2M 30.98x $0.00 0% 3.84x
INFU
InfuSystem Holdings, Inc.
$8.67 $14.20 $176.3M 33.15x $0.00 0% 1.30x
LUNG
Pulmonx Corp.
$2.04 $5.75 $84.1M -- $0.00 0% 0.90x
QSI
Quantum-Si, Inc.
$1.22 $2.68 $262.9M -- $0.00 0% 69.25x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ADTX
Aditxt, Inc.
692.23% 4.083 345.85% 0.01x
CATX
Perspective Therapeutics, Inc.
1.35% 3.042 1.3% 8.47x
ELMD
Electromed, Inc.
-- 1.105 -- 4.58x
INFU
InfuSystem Holdings, Inc.
30.8% 4.042 11.73% 1.35x
LUNG
Pulmonx Corp.
48.51% -2.042 84.65% 3.96x
QSI
Quantum-Si, Inc.
1.92% 5.259 1.52% 10.24x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ADTX
Aditxt, Inc.
-$67.5K -$3.1M -319.72% -681.25% -448657.14% -$2.3M
CATX
Perspective Therapeutics, Inc.
-$566K -$27.9M -37.13% -37.63% -13330.62% -$18.3M
ELMD
Electromed, Inc.
$13.2M $2.7M 18.88% 18.89% 15.81% -$98K
INFU
InfuSystem Holdings, Inc.
$20.3M $3.8M 6.43% 9.93% 10.45% $8.4M
LUNG
Pulmonx Corp.
$16M -$14.4M -42.41% -73.42% -66.94% -$8.3M
QSI
Quantum-Si, Inc.
-$979K -$24.4M -49.36% -51.75% -4419.57% -$32.9M

Aditxt, Inc. vs. Competitors

  • Which has Higher Returns ADTX or CATX?

    Perspective Therapeutics, Inc. has a net margin of -3458242.86% compared to Aditxt, Inc.'s net margin of -12425.36%. Aditxt, Inc.'s return on equity of -681.25% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.

    Company Gross Margin Earnings Per Share Invested Capital
    ADTX
    Aditxt, Inc.
    -9642.86% -$548.81 $179.3K
    CATX
    Perspective Therapeutics, Inc.
    -270.81% -$0.35 $245.5M
  • What do Analysts Say About ADTX or CATX?

    Aditxt, Inc. has a consensus price target of --, signalling upside risk potential of 897058723.53%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 333.37%. Given that Aditxt, Inc. has higher upside potential than Perspective Therapeutics, Inc., analysts believe Aditxt, Inc. is more attractive than Perspective Therapeutics, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    ADTX
    Aditxt, Inc.
    0 0 0
    CATX
    Perspective Therapeutics, Inc.
    12 1 0
  • Is ADTX or CATX More Risky?

    Aditxt, Inc. has a beta of 1.282, which suggesting that the stock is 28.184% more volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.182, suggesting its more volatile than the S&P 500 by 18.151%.

  • Which is a Better Dividend Stock ADTX or CATX?

    Aditxt, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aditxt, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ADTX or CATX?

    Aditxt, Inc. quarterly revenues are $700, which are smaller than Perspective Therapeutics, Inc. quarterly revenues of $209K. Aditxt, Inc.'s net income of -$24.2M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Aditxt, Inc.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aditxt, Inc. is 25.68x versus 192.56x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ADTX
    Aditxt, Inc.
    25.68x -- $700 -$24.2M
    CATX
    Perspective Therapeutics, Inc.
    192.56x -- $209K -$26M
  • Which has Higher Returns ADTX or ELMD?

    Electromed, Inc. has a net margin of -3458242.86% compared to Aditxt, Inc.'s net margin of 12.65%. Aditxt, Inc.'s return on equity of -681.25% beat Electromed, Inc.'s return on equity of 18.89%.

    Company Gross Margin Earnings Per Share Invested Capital
    ADTX
    Aditxt, Inc.
    -9642.86% -$548.81 $179.3K
    ELMD
    Electromed, Inc.
    78.15% $0.25 $44.7M
  • What do Analysts Say About ADTX or ELMD?

    Aditxt, Inc. has a consensus price target of --, signalling upside risk potential of 897058723.53%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 25%. Given that Aditxt, Inc. has higher upside potential than Electromed, Inc., analysts believe Aditxt, Inc. is more attractive than Electromed, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    ADTX
    Aditxt, Inc.
    0 0 0
    ELMD
    Electromed, Inc.
    4 0 0
  • Is ADTX or ELMD More Risky?

    Aditxt, Inc. has a beta of 1.282, which suggesting that the stock is 28.184% more volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.266, suggesting its less volatile than the S&P 500 by 73.442%.

  • Which is a Better Dividend Stock ADTX or ELMD?

    Aditxt, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aditxt, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ADTX or ELMD?

    Aditxt, Inc. quarterly revenues are $700, which are smaller than Electromed, Inc. quarterly revenues of $16.9M. Aditxt, Inc.'s net income of -$24.2M is lower than Electromed, Inc.'s net income of $2.1M. Notably, Aditxt, Inc.'s price-to-earnings ratio is -- while Electromed, Inc.'s PE ratio is 30.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aditxt, Inc. is 25.68x versus 3.84x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ADTX
    Aditxt, Inc.
    25.68x -- $700 -$24.2M
    ELMD
    Electromed, Inc.
    3.84x 30.98x $16.9M $2.1M
  • Which has Higher Returns ADTX or INFU?

    InfuSystem Holdings, Inc. has a net margin of -3458242.86% compared to Aditxt, Inc.'s net margin of 6.19%. Aditxt, Inc.'s return on equity of -681.25% beat InfuSystem Holdings, Inc.'s return on equity of 9.93%.

    Company Gross Margin Earnings Per Share Invested Capital
    ADTX
    Aditxt, Inc.
    -9642.86% -$548.81 $179.3K
    INFU
    InfuSystem Holdings, Inc.
    55.65% $0.11 $80.2M
  • What do Analysts Say About ADTX or INFU?

    Aditxt, Inc. has a consensus price target of --, signalling upside risk potential of 897058723.53%. On the other hand InfuSystem Holdings, Inc. has an analysts' consensus of $14.20 which suggests that it could grow by 63.78%. Given that Aditxt, Inc. has higher upside potential than InfuSystem Holdings, Inc., analysts believe Aditxt, Inc. is more attractive than InfuSystem Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    ADTX
    Aditxt, Inc.
    0 0 0
    INFU
    InfuSystem Holdings, Inc.
    5 0 0
  • Is ADTX or INFU More Risky?

    Aditxt, Inc. has a beta of 1.282, which suggesting that the stock is 28.184% more volatile than S&P 500. In comparison InfuSystem Holdings, Inc. has a beta of 1.680, suggesting its more volatile than the S&P 500 by 68.01%.

  • Which is a Better Dividend Stock ADTX or INFU?

    Aditxt, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystem Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aditxt, Inc. pays -- of its earnings as a dividend. InfuSystem Holdings, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ADTX or INFU?

    Aditxt, Inc. quarterly revenues are $700, which are smaller than InfuSystem Holdings, Inc. quarterly revenues of $36.5M. Aditxt, Inc.'s net income of -$24.2M is lower than InfuSystem Holdings, Inc.'s net income of $2.3M. Notably, Aditxt, Inc.'s price-to-earnings ratio is -- while InfuSystem Holdings, Inc.'s PE ratio is 33.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aditxt, Inc. is 25.68x versus 1.30x for InfuSystem Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ADTX
    Aditxt, Inc.
    25.68x -- $700 -$24.2M
    INFU
    InfuSystem Holdings, Inc.
    1.30x 33.15x $36.5M $2.3M
  • Which has Higher Returns ADTX or LUNG?

    Pulmonx Corp. has a net margin of -3458242.86% compared to Aditxt, Inc.'s net margin of -64.91%. Aditxt, Inc.'s return on equity of -681.25% beat Pulmonx Corp.'s return on equity of -73.42%.

    Company Gross Margin Earnings Per Share Invested Capital
    ADTX
    Aditxt, Inc.
    -9642.86% -$548.81 $179.3K
    LUNG
    Pulmonx Corp.
    74.19% -$0.34 $116.6M
  • What do Analysts Say About ADTX or LUNG?

    Aditxt, Inc. has a consensus price target of --, signalling upside risk potential of 897058723.53%. On the other hand Pulmonx Corp. has an analysts' consensus of $5.75 which suggests that it could grow by 181.86%. Given that Aditxt, Inc. has higher upside potential than Pulmonx Corp., analysts believe Aditxt, Inc. is more attractive than Pulmonx Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    ADTX
    Aditxt, Inc.
    0 0 0
    LUNG
    Pulmonx Corp.
    4 2 0
  • Is ADTX or LUNG More Risky?

    Aditxt, Inc. has a beta of 1.282, which suggesting that the stock is 28.184% more volatile than S&P 500. In comparison Pulmonx Corp. has a beta of 0.105, suggesting its less volatile than the S&P 500 by 89.488%.

  • Which is a Better Dividend Stock ADTX or LUNG?

    Aditxt, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pulmonx Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aditxt, Inc. pays -- of its earnings as a dividend. Pulmonx Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ADTX or LUNG?

    Aditxt, Inc. quarterly revenues are $700, which are smaller than Pulmonx Corp. quarterly revenues of $21.5M. Aditxt, Inc.'s net income of -$24.2M is lower than Pulmonx Corp.'s net income of -$14M. Notably, Aditxt, Inc.'s price-to-earnings ratio is -- while Pulmonx Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aditxt, Inc. is 25.68x versus 0.90x for Pulmonx Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ADTX
    Aditxt, Inc.
    25.68x -- $700 -$24.2M
    LUNG
    Pulmonx Corp.
    0.90x -- $21.5M -$14M
  • Which has Higher Returns ADTX or QSI?

    Quantum-Si, Inc. has a net margin of -3458242.86% compared to Aditxt, Inc.'s net margin of -6467.94%. Aditxt, Inc.'s return on equity of -681.25% beat Quantum-Si, Inc.'s return on equity of -51.75%.

    Company Gross Margin Earnings Per Share Invested Capital
    ADTX
    Aditxt, Inc.
    -9642.86% -$548.81 $179.3K
    QSI
    Quantum-Si, Inc.
    -177.36% -$0.17 $239.8M
  • What do Analysts Say About ADTX or QSI?

    Aditxt, Inc. has a consensus price target of --, signalling upside risk potential of 897058723.53%. On the other hand Quantum-Si, Inc. has an analysts' consensus of $2.68 which suggests that it could grow by 119.95%. Given that Aditxt, Inc. has higher upside potential than Quantum-Si, Inc., analysts believe Aditxt, Inc. is more attractive than Quantum-Si, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    ADTX
    Aditxt, Inc.
    0 0 0
    QSI
    Quantum-Si, Inc.
    2 1 0
  • Is ADTX or QSI More Risky?

    Aditxt, Inc. has a beta of 1.282, which suggesting that the stock is 28.184% more volatile than S&P 500. In comparison Quantum-Si, Inc. has a beta of 3.018, suggesting its more volatile than the S&P 500 by 201.845%.

  • Which is a Better Dividend Stock ADTX or QSI?

    Aditxt, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quantum-Si, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aditxt, Inc. pays -- of its earnings as a dividend. Quantum-Si, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ADTX or QSI?

    Aditxt, Inc. quarterly revenues are $700, which are smaller than Quantum-Si, Inc. quarterly revenues of $552K. Aditxt, Inc.'s net income of -$24.2M is higher than Quantum-Si, Inc.'s net income of -$35.7M. Notably, Aditxt, Inc.'s price-to-earnings ratio is -- while Quantum-Si, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aditxt, Inc. is 25.68x versus 69.25x for Quantum-Si, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ADTX
    Aditxt, Inc.
    25.68x -- $700 -$24.2M
    QSI
    Quantum-Si, Inc.
    69.25x -- $552K -$35.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Why Did Planet Labs Stock Rally So Much?
Why Did Planet Labs Stock Rally So Much?

Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
100
ATGL alert for Jan 10

Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.

Buy
71
NAIL alert for Jan 10

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.

Buy
54
LGIH alert for Jan 10

LGI Homes, Inc. [LGIH] is up 13.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock